TABLE 3.
Grouping variable(s) | Proportion of detected samples out of total samples | Two-sided 95% confidence limit | ||||
---|---|---|---|---|---|---|
Pathogen type | Target (expected) | Concentration | Fraction | % | Lower | Upper |
Bacteria | Mycoplasma pneumoniae | 3.16× LoD | 26/26 | 100.00 | 87.13 | 100.00 |
0.63× LoD | 35/35 | 100.00 | 90.11 | 100.00 | ||
Neisseria meningitidis | 6.33× LoD | 27/27 | 100.00 | 87.54 | 100.00 | |
31.6× LoD | 38/38 | 100.00 | 90.82 | 100.00 | ||
Streptococcus agalactiae | 3.16× LoD | 24/25 | 96.00 | 80.46 | 99.29 | |
0.63× LoD | 36/36 | 100.00 | 90.36 | 100.00 | ||
Streptococcus pyogenes | 3.16× LoD | 25/25 | 100.00 | 86.68 | 100.00 | |
0.63× LoD | 36/36 | 100.00 | 90.36 | 100.00 | ||
Virus | Enterovirus | 3.16× LoD | 58/60 | 96.67 | 88.64 | 99.08 |
Human parechovirus | 3.16× LoD | 59/59 | 100.00 | 93.89 | 100.00 |
Contrived samples were considered valid if the correct pathogen was detected using the QIAstat-Dx ME Panel assay.